Skip to main content
. 2021 Oct 20;15(1):101250. doi: 10.1016/j.tranon.2021.101250

Fig. 3.

Fig 3

Kaplan-Meier survival analysis and logrank test show a significant association between the USP8 expression and the survival of LIHC patient. For Kaplan-Meier survival analysis on 20 different cancers (provided by OncoRank (http://www.oncolnc.org), (A) BLCA, Bladder Urothelial Carcinoma; (B) BRCA, Breast Invasive Carcinoma; (C) COAD, Colon Adenocarcinoma; (D) ESCA, Esophageal Carcinoma; (E) GBM, Glioblastoma Multiforme; (F) HNSC, Head and Neck Squamous Cell Carcinoma; (G) KIRP, Kidney Renal Papillary Cell Carcinoma; (H) LAML Acute Myeloid Leukemia; (I) LGG, Brain Lower Grade Glioma; (J) LUAD, Lung Adenocarcinoma; (K) LUSC, Lung Squamous Cell Carcinoma; (L) OV, Ovary Serous Cystadenocarcinoma; (M) PAAD, Pancreatic Adenocarcinoma; (N) READ, Rectum Adenocarcinoma; (O) SARC, Sarcoma; (P) SKCM, Skin Cutaneous Melanoma; (Q) STAD, Stomach Adenocarcinoma; (R) UCEC, Uterine Corpus Endometrial Carcinoma; (S) LIHC, Liver Hepatocellular Carcinoma; (T) KIRC, Kidney Renal Clear Cell Carcinoma, the patients were categorized into high-expression group (upper 50 percentile, red curve) and low-expression group (lower 50 percentile, blue curve) based on USP8 gene expression levels. (U and V) The combined Kaplan-Meier overall (U) or disease free (V) survival analysis was performed using GAPIA TCGA data. The number of patients in each group and the p-value were represented.